President Trump recently announced that trademarked or patented pharmaceutical products will be subject to a 100 percent tariff starting October 1, 2025 – unless the manufacturer establishes a product...

Innovation is obviously a key component of future competitiveness. Consequently, the very same stakeholders from industry, academia.

The financing was led by Mellby Gård with strong support from AMF, Ramsbury and existing shareholders, alongside new investors.

Even though many have tried and few succeeded in the quest to find viable treatments for neurodegenerative diseases.

At a White House press event yesterday, Wednesday April 2, President Trump advanced the next stage of his economic plan by unveiling baseline tariffs of 10% on the vast majority of goods imported to t...

Researchers at Karolinska Institutet have developed a method that shows how the nervous system and sensory organs are formed in an embryo.

Cardiovascular diseases have a high mortality rate and although prevention is key, there are many companies, including Nordic ones.

EsoBiotec is a biotechnology company focusing on in vivo cell therapies that has demonstrated promising early clinical activity.

As always, JPM kicks off the year as the key event for life science executives to exchange insights and predict the direction of the industry.

Professor Kirsi Pietiläinen receives the Novo Nordisk Foundation prize for her outstanding work in clinical metabolism.

The Nobel Prize laureates protest against Russia's war of invasion and the world's inaction, and they demand that EUR 300 billion in frozen Russian assets be given to Ukraine.

The future of Europe depends on the future of European life science competitiveness. So far, everyone seems to agree.

Abera Bioscience reports that its first in vivo study with a novel nasal influenza vaccine candidate has delivered promising results.

The Gates Foundation, Novo Nordisk Foundation, and Wellcome have announced the launch of the Gram-Negative Antibiotic Discovery Innovator.

The Crafoord Prize in Polyarthritis 2025, worth SEK six million, is awarded to Christopher Goodnow, Australia, and David Nemazee, USA.

The team behind NordicRWE believe the possibilities of Real-World Evidence are obvious, but access to and sharing data.

The investment in Canada will create more than 700 high-skilled jobs, across all areas of the business.

CSL Behring Denmark has announced that the first Danish patients with haemophilia B were treated with the gene therapy HEMGENIX.

The Human Protein Atlas, one of the world’s largest biological databases, gives us a more profound understanding of protein expression.

Gesynta Pharma has secured SEK 304 million in a Series B financing round led by Innovestor Life Science.

SwedenBIO and Biocom have signed a memorandum of understanding (MOU) to undertake cooperative activities they state.

According to Professor Matthias Christandl, the potential of quantum computing within life sciences is enormous.

A strong collective will has emerged during these challenging times. The Finnish economy has had difficulties achieving robust growth.

Vicore Pharma is praised for being at the forefront of addressing unmet medical needs in rare diseases and for securing.

The 2024 Nobel Prizes in Chemistry and Physics reflect the revolutionary impact of artificial intelligence (AI) on life sciences.

When it comes to life science, one of the strengths of Norway and the Nordics is basic and translational immunology.

David Baker, born in Seattle in 1962, is an American professor of biochemistry and computational biology at the University of Washington.

In this year’s Nobel Week Dialogue, Nobel Prize laureates and other experts will gather to discuss and envision our future.

Victor Ambros, Professor of Molecular Medicine and the Silverman Chair in Natural Sciences at the University of Massachusetts Chan.

First, I would like to congratulate all the new Nobel Prize winners awarded by The Royal Swedish Academy of Sciences in October.

American IonQ has set up in Gothenburg, primarily through a new development center at AstraZeneca BioVentureHub.

In today’s rapidly shifting global landscape, it’s clear that the future of humanity hinges on how we invest in people.

Danish and Swedish life science strategies under the lens at Medicon Valley Alliance Annual Meeting.

During the World AMR Awareness Week (WAAW) NLS has chosen to highlight different Nordic companies and investors sharing what part of the solution they bring to the table and how their impact can be le...

The Nordics is a small region and access to capital is limited, so many biotech companies do not have the financial strength to develop.

During the World AMR Awareness Week (WAAW) NLS has chosen to highlight different Nordic companies and investors sharing what part of the solution they bring to the table and how their impact can be le...

Xbrane Biopharma and Intas Pharmaceuticals have announced an exclusive global licensing and co-development agreement.

NLS asked Fredrik Schjesvold, MD, PhD, founder and leader of Oslo Myeloma Center, Oslo University Hospital, about the ongoing debate.

All over the Nordics the innovative power is gearing up to put new products, therapies, and preventive measures on the market that will tackle Antimicrobial resistance (AMR) from various angles.

Start-up company AdjuTec’s novel antibiotic resistance breakers may help to facilitate reduced use of antibiotics.

NordForsk has decided to fund six Nordic research networks that will apply for EU calls in the field of antimicrobial resistance (AMR).

The innovation gap between the EU and its competitors continues to widen while the number of EU regulations affecting the industry is rising.

His is not a household name, but the drugs developed thanks to Danish scientist Jens Juul Holst’s research certainly are.